Aging (Aging-US)’s Post

🔍 Discover the latest advancements in treating kidney cancer with insights from Mayo Clinic's Dr. Aaron Potretzke. 📢 Learn about innovative surgical techniques, ablation methods, and active surveillance strategies that are enhancing patient outcomes. Explore how these cutting-edge treatments are preserving kidney function and improving quality of life for kidney cancer patients. #KidneyCancer #InnovativeSurgery #Oncology #Health

ALBI score combined with FIB-4 index to predict post-hepatectomy liver failure in patients with hepatocellular carcinoma 🔪 #SurgicalOncology #SurgOnc #Oncology #Cancer

What Is the MAF Test® and How It’s Shaping Breast Cancer Treatment? The MAF Test® by Inbiomotion is a revolutionary diagnostic test for early breast cancer patients enabling more personalized care. Traditionally, the ESMO/ASCO guidelines for breast cancer bisphosphonates adjuvant treatment stratify patients based on menopausal status. However, by measuring the amplification of the MAF gene, the MAF Test® provides new insights by identifying patients who may benefit from bisphosphonates, regardless of menopausal status. By moving beyond traditional stratification methods, the MAF Test® helps oncologists tailor treatment plans more effectively, improving outcomes and minimizing unnecessary interventions. For more information: https://lnkd.in/eQCkR_F4 #Oncology #BreastCancer #PersonalizedMedicine #HealthcareInnovation

Recent research sheds light on rising pancreatic cancer rates among young adults. While cases have doubled since 2001, especially in early-stage endocrine tumors, there hasn’t been a corresponding increase in deaths. This suggests that advanced imaging techniques are identifying more nonlethal cases earlier, emphasizing the importance of distinguishing between overdiagnosis and actionable findings. These insights are critical as we refine diagnostic approaches and consider the risks associated with unnecessary surgeries for non-aggressive cases. #CancerResearch #PancreaticCancer #EarlyDetection #HealthcareInnovation #MedicalResearch #PublicHealth

The CAM model is ideal for personalized medicine, especially for PDAC. It supports human tumor tissues without immune rejection and allows easy monitoring. Its simplicity, low cost, and reproducibility make it excellent for studying tumors and testing therapies, bridging the gap between cell-based and animal assays. https://lnkd.in/g_PsZ_AT #pancreaticcancer #PDAC #metastasis #chorioallantoicmembrane #CAMmodel #PCR #drugtargeting #drugrelease #personalizedmedicine #oncology #cancertherapy

A new and simple model to predict patient survival in advanced pancreatic cancer #pancreatic_cancer #patient_survival #gamma_glutamyl_transferase #lactate_dehydrogenase #monocytes https://lnkd.in/dFVHbvUk

A new research explored a link between breast cancer 🎗️, hematopoietic cell transplants (HCTs), an increase in physical frailty, and cellular senescence. https://lnkd.in/df92RRG9 by Josh Conway  #aging #longevity #lifespan #healthspan #geroscience #BiologyOfAging

City of Hope is redefining predictive sepsis detection for its bone marrow transplant patients. Check out this article in The New Stack to learn how City of Hope’s real-time AI prediction model (powered by Confluent) makes sepsis predictions easier and helps keep patients healthy during their cancer treatment processes:

City of Hope is redefining predictive sepsis detection for its bone marrow transplant patients. Check out this article in The New Stack to learn how City of Hope’s real-time AI prediction model (powered by Confluent) makes sepsis predictions easier and helps keep patients healthy during their cancer treatment processes:

City of Hope is redefining predictive sepsis detection for its bone marrow transplant patients. Check out this article in The New Stack to learn how City of Hope’s real-time AI prediction model (powered by Confluent) makes sepsis predictions easier and helps keep patients healthy during their cancer treatment processes: